Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - veirueyðandi lyf til almennrar notkunar - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

sanofi winthrop industrie - insúlín aspart - sykursýki - lyf notuð við sykursýki - truvelog mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.

Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.

Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegravir - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 og 5.

Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

gilead sciences ireland uc - cobicistat - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 60 míkróg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 240 míkróg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 120 míkróg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

zentiva k.s.* - desmopressinum acetat - tungurótartafla - 120 míkróg